Company / Depreciation & Amortization
Bausch & Lomb Corp Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$421.0M
FY2025
5-year range
$379.0M / $436.0M
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
#24 of 135
Health Care
What the data says
Bausch & Lomb Corp's depreciation & amortization of $421M is higher than 82% of companies in the Health Care sector (FY2025). Increased from $382M to $421M over the past 2 years.
Based on SEC 10-K filings.
$421M in FY2025 with a 5-year CAGR of -1.0%. Top quartile in the Health Care sector.
Increased from $382M to $421M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 135This company $421.0M Sector average $334.5M
▼
+25.9% above sector average
Key checks
Key Insights
- 5-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 3.4% year-over-year.
- Ranks #24 out of 135 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $421.0M | -3.4% |
| FY2024 | $436.0M | +14.1% |
| FY2023 | $382.0M | +0.8% |
| FY2022 | $379.0M | -8.7% |
| FY2021 | $415.0M | -6.1% |
| FY2020 | $442.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026